Industry Symposia

Friday, March 1st, 2024, 12:05-12:25pm ET
Advances in Basal Insulin: Practical uses from a Clinician’s Perspective

Novella (Breakout Room)

At the end of this session, attendees will be able to:

  • Discuss the practical aspects of managing innovative basal insulin for patients with type 2 diabetes
  • Differentiate the clinical challenges and advantages between basal insulin options for treatment of type 2 diabetes

Jonathan Vecchiarelli

Dr. Jonathan Vecchiarelli MD FRCPC
LMC Diabetes and Endocrinology

Friday, March 1st, 2024, 12:40-1:00pm ET
Changing the Story of Type 1 Diabetes

Novella (Breakout Room)

This session will focus on Type 1 Diabetes (T1D) as an autoimmune disorder, delving into its effects on beta cells. Exploring different screening goals and the role of screening in identifying people at risk. Furthermore, we’ll spotlight clinical research initiatives aimed at safeguarding beta cell function and impeding disease advancement.

Bruce Perkins

Dr. Bruce A. Perkins MD MPH FRCP(C)
Professor of Medicine and Clinician-Scientist, University of Toronto
The Sam and Judy Pencer Family Chair in Diabetes
Director of the Diabetes Clinical Research Unit, Sinai Health System